These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2027518)

  • 1. N-[1-(2-thienyl)cyclohexyl]-piperidine (TCP) does not block kainic acid-induced status epilepticus but reduces secondary hippocampal damage.
    Lerner-Natoli M; Rondouin G; Belaidi M; Baldy-Moulinier M; Kamenka JM
    Neurosci Lett; 1991 Jan; 122(2):174-8. PubMed ID: 2027518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Excitotoxic damage of the hippocampus in the rat: involvement of N-methyl-D-aspartate receptors].
    Belaidi M; Rondouin G; Lerner-Natoli M; N'Gouemo P; Kamenka JM
    C R Seances Soc Biol Fil; 1989; 183(3):256-62. PubMed ID: 2532560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal damage induced by ischemia and intra-amygdaloid kainate injection: effect on N-methyl-D-aspartate, N-(1-[2-thienyl]cyclohexyl)piperidine and glycine binding sites.
    Crepel V; Represa A; Beaudoin M; Ben-Ari Y
    Neuroscience; 1989; 31(3):605-12. PubMed ID: 2556659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C; Arvin B; Le Peillet E; Meldrum BS
    Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A paradox after systemic kainate injection in rats: lesser damage of hippocampal CA1 neurons after higher doses.
    Balchen T; Berg M; Diemer NH
    Neurosci Lett; 1993 Dec; 163(2):151-4. PubMed ID: 8309622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCP shortens the latency of onset of isoelectricity in hypoglycaemia and fails to protect striatal neurones and dentate gyrus granule cells from hypoglycaemic injury in rats.
    Torres JH; Rondouin G; Kamenka JM; Chicheportiche R
    Neurosci Lett; 1990 Nov; 120(1):80-3. PubMed ID: 2293098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate.
    Stone TW
    Br J Pharmacol; 1990 Dec; 101(4):847-52. PubMed ID: 1964821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist.
    Fariello RG; Golden GT; Smith GG; Reyes PF
    Epilepsy Res; 1989; 3(3):206-13. PubMed ID: 2543557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoromethylated and hydroxymethylated derivatives of N-methyl-D-aspartate receptor antagonist 1-[1-(2-thienyl)cyclohexyl]piperidine.
    Tsukiyama S; Hashimoto A; Katayama S; Nishikawa T; Tobe A; Maeda M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1581-4. PubMed ID: 1834357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anaesthetics, anticonvulsants and glutamate antagonists on kainic acid-induced local and distal neuronal loss.
    Lees GJ
    J Neurol Sci; 1992 Apr; 108(2):221-8. PubMed ID: 1517756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotoxicity of intrahippocampal kainic acid injection in rats is not accompanied by a reduction of Timm stain.
    Théorêt Y; Earnhardt TS; Bouldin TW; Krigman MR
    Brain Res; 1988 May; 449(1-2):341-6. PubMed ID: 2456130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kainic acid dose affects delayed cell death mechanism after status epilepticus.
    Tokuhara D; Sakuma S; Hattori H; Matsuoka O; Yamano T
    Brain Dev; 2007 Jan; 29(1):2-8. PubMed ID: 16790331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of D-(-)-aminophosphonovalerate on behavioral and histological changes induced by systemic kainic acid.
    Lason W; Simpson JN; McGinty JF
    Neurosci Lett; 1988 Apr; 87(1-2):23-8. PubMed ID: 2898113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahippocampal injection of kainic acid produces significant pyramidal cell loss in neonatal rats.
    Cook TM; Crutcher KA
    Neuroscience; 1986 May; 18(1):79-92. PubMed ID: 3736859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain.
    Hosford DA; Bonhaus DW; McNamara JO
    Brain Res; 1990 May; 516(2):192-200. PubMed ID: 1694710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal damage after intra-amygdala kainic acid-induced status epilepticus and seizure preconditioning-mediated neuroprotection in SJL mice.
    Tanaka K; Jimenez-Mateos EM; Matsushima S; Taki W; Henshall DC
    Epilepsy Res; 2010 Feb; 88(2-3):151-61. PubMed ID: 19931419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of temporal expressions of FOXO and pFOXO proteins in the hippocampus by kainic acid in mice: involvement of NMDA and non-NMDA receptors.
    Park SH; Sim YB; Lee JK; Lee JY; Suh HW
    Arch Pharm Res; 2016 May; 39(5):660-7. PubMed ID: 26987339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling.
    Haas KZ; Sperber EF; Opanashuk LA; Stanton PK; Moshé SL
    Hippocampus; 2001; 11(6):615-25. PubMed ID: 11811655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory amino acid binding sites in the rat hippocampus after transient forebrain ischemia.
    Onodera H; Araki T; Kogure K
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):623-8. PubMed ID: 2550493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.